Full Year 2022 Pacific Edge Ltd Earnings Call Transcript
An important disclaimer. Note that by participating on this call, you agree and understand these terms and conditions. Today with me, I also have our CFO, Grant Gibson, who will be speaking to some of the financial results and also available to ask a question.
Our news for today is focused on some highlights of the results and, a little bit about the company, a look at our operational performance over the financial period and then some framing of our investment program based on the capital raise we did last year. We'll look at the specifics of our financial performance, and we'll make some statements regarding the outlook, and then there'll be the opportunity for all of you to ask us questions.
So diving right into the highlights. Global testing volumes are up 46%. U.S. testing volumes total laboratory throughput are up by 59%. Growth in operating revenue is up 49%, and all of this comes with a slight increase to $19.8 million net loss after tax. And importantly, we still have a very healthy cash balance with $105.4 million cash equivalents and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |